eikontx.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $2.42B
Eikon Therapeutics is a drug discovery and development business focused on the movements of single proteins within cells. Eikon's proprietary microscopes can visualize the movement within these cells. Eikon Therapeutics was founded in 2019 by Luke Lavis, Robert Tjian Ph.D., Xavier Darzacq Ph.D., and Eric Betzig and is headquartered in Hayward, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/16/2023 | Series C | $535MM | $xx.xx | $4.74B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
24,884,830
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
01/06/2022 | Series B | $525MM | $xx.xx | $3.1B | Adia, Ame Cloud Ventures, Canada Pension Plan Investment Board, E15 Vc, Ecor1 Capital, Foresite Capital, General Catalyst, Harel Insurance, Hartford Healthcare Endowment, Horizon Ventures, Inc, Innovaction Endeavors, Lux Capital, Schroders Capital, Soros Capital, Stepstone Group, The Column Group, T. Rowe Price Associates, Uc Investments | |
Price per Share
$xx.xx
Shares Outstanding
29,680,164
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Adia, Ame Cloud Ventures, Canada Pension Plan Investment Board, E15 Vc, Ecor1 Capital, Foresite Capital, General Catalyst, Harel Insurance, Hartford Healthcare Endowment, Horizon Ventures, Inc, Innovaction Endeavors, Lux Capital, Schroders Capital, Soros Capital, Stepstone Group, The Column Group, T. Rowe Price Associates, Uc Investments
|
||||||
05/05/2021 | Series A | $48MM | $xx.xx | $248.17MM | Foresite Capital, Innovation Endeavors, Lux Capital, The Column Group | |
Price per Share
$xx.xx
Shares Outstanding
48,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Foresite Capital, Innovation Endeavors, Lux Capital, The Column Group
|
||||||
05/05/2021 | Series A-1 | $102.54MM | $xx.xx | $248.17MM | Foresite Capital, Innovation Endeavors, Lux Capital, The Column Group | |
Price per Share
$xx.xx
Shares Outstanding
51,268,891
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Foresite Capital, Innovation Endeavors, Lux Capital, The Column Group
|